论文部分内容阅读
目的:评价红霉素用药后阿奇霉素序贯疗法对支原体肺炎患儿伴哮喘的临床疗效,以及支原体肺炎与哮喘的关系。方法:选取2014年3月—2016年3月间收治的支原体肺炎伴支气管哮喘患儿148例,将其分为治疗组和对照组,每组74例;对照组患儿给予常规治疗,治疗组患儿给予红霉素与阿奇霉素联用治疗,比较两组患儿治疗后总有效率,以及治疗后肺通气功能各指标测得值的变化情况。结果:治疗组患儿治疗后的总有效率明显高于对照组(P<0.05),肺通气功能各指标测得值明显优于对照组(P<0.05)。结论:采用红霉素与阿奇霉素联用治疗支原体肺炎患儿伴哮喘患者,对支原体肺炎所致哮喘的临床疗效较为显著,改善了其肺通气功能各指标。
Objective: To evaluate the clinical efficacy of sequential therapy with azithromycin in children with mycoplasma pneumonia following asthma, and the relationship between mycoplasma pneumonia and asthma. Methods: A total of 148 children with mycoplasma pneumonia and bronchial asthma were selected from March 2014 to March 2016, and divided into treatment group and control group, with 74 cases in each group. The control group received routine treatment and the treatment group Erythromycin in children with azithromycin combined treatment, compared the two groups of children after treatment, the total effective rate, as well as after treatment, pulmonary ventilation function measured values ?? of the changes. Results: The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). The indexes of pulmonary function were significantly better than those of the control group (P <0.05). Conclusion: The combination of erythromycin and azithromycin in patients with mycoplasma pneumonia with asthma in patients with mycoplasma pneumonia-induced asthma clinical efficacy is more significant to improve the various indicators of pulmonary ventilation.